ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,731Medicare Part D Prescriptions Filled, Including Refills

Rank: 86 out of 3647

$1.08M Total Retail Price of All Prescriptions

Rank: 187 out of 3647

1,017 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 1,017 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

22% of this provider’s 1,017 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 20,239 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 1,166 914 1 1
HYDROCODONE-ACETAMINOPHEN 1,162 721 S3 2 12
OMEPRAZOLE 954 733 3 3
LISINOPRIL 855 595 4 4
AMLODIPINE BESYLATE 844 666 5 2
LEVOTHYROXINE SODIUM 729 590 6 5
LOSARTAN POTASSIUM 598 439 7 11
CARVEDILOL 562 404 8 20
METFORMIN HCL 561 407 9 6
FUROSEMIDE 502 406 10 8
CLONIDINE HCL 460 320 11 46
METOPROLOL TARTRATE 438 359 12 7
ALPRAZOLAM 404 271 13 31
CITALOPRAM HBR 325 261 14 25
ALENDRONATE SODIUM 322 303 15 23
HYDROCHLOROTHIAZIDE 322 224 15 9
POTASSIUM CHLORIDE 320 262 17 24
AZITHROMYCIN 317 209 18 34
GABAPENTIN 307 167 19 17
ZOLPIDEM TARTRATE 297 192 20 14
LOVASTATIN 292 275 21 21
PANTOPRAZOLE SODIUM 280 191 22 38
PROAIR HFA 276 126 23 62
GLIMEPIRIDE 270 179 24 45
ATENOLOL 268 222 25 10
CLOPIDOGREL 267 224 26 26
ENALAPRIL MALEATE 240 173 27 35
RANITIDINE HCL 240 172 27 29
PLAVIX 230 204 29 39
LOSARTAN-HYDROCHLOROTHIAZIDE 224 186 30 48
GLYBURIDE 220 179 R 31 54
DONEPEZIL HCL 220 220 31 30
WARFARIN SODIUM 216 178 33 15
METOPROLOL SUCCINATE 213 176 34 18
ADVAIR DISKUS 209 97 35 52
FLUTICASONE PROPIONATE 200 128 36 32
DIGOXIN 190 157 37 51
PRAVASTATIN SODIUM 188 159 38 16
BACLOFEN 187 131 39 97
PREDNISONE 176 128 40 43
PAROXETINE HCL 174 128 41 60
MELOXICAM 165 128 42 33
FAMOTIDINE 162 140 43 61
FINASTERIDE 160 146 44 66
TRAMADOL HCL 156 110 45 22
ISOSORBIDE MONONITRATE ER 155 114 46 56
LISINOPRIL-HYDROCHLOROTHIAZIDE 153 129 47 36
TEMAZEPAM 152 114 48 47
ALLOPURINOL 144 118 49 37
TAMSULOSIN HCL 144 131 49 28
TRIAMTERENE-HCTZ 133 130 51 58
LEVOFLOXACIN 128 106 52 87
DIOVAN 122 89 53 40
METFORMIN HCL ER 119 57 54 92
POLYETHYLENE GLYCOL 3350 116 75 55 143
SERTRALINE HCL 116 81 55 27
METHYLPREDNISOLONE 115 82 57 78
ATORVASTATIN CALCIUM 115 87 57 13
EVISTA 114 103 59 184
FLUOXETINE HCL 113 77 60 68
CARISOPRODOL 112 19 R 61 115
AMITRIPTYLINE HCL 107 53 R 62 105
RAMIPRIL 106 93 63 101
VENTOLIN HFA 104 43 64 88
INSULIN SYRINGE 104 53 64 76
MECLIZINE HCL 102 80 66 85
CIPROFLOXACIN HCL 102 85 66 53
SINGULAIR 97 66 68 90
ROPINIROLE HCL 97 88 68 151
LANTUS SOLOSTAR 94 61 70 124
OXYCODONE HCL 94 24 S2 70 75
FENTANYL 93 65 S2 72 147
AMOX TR-POTASSIUM CLAVULANATE 90 58 73 118
SILVER SULFADIAZINE 90 56 73 243
AMOXICILLIN 89 60 75 133
DILTIAZEM ER 89 85 75 167
OXYBUTYNIN CHLORIDE 87 67 77 107
LORAZEPAM 87 61 77 73
AMLODIPINE BESYLATE-BENAZEPRIL 86 60 79 74
TRAZODONE HCL 85 31 80 64
PEN NEEDLE 83 69 81 166
NIFEDIPINE ER 83 77 81 67
GEMFIBROZIL 78 61 83 82
OXYCODONE-ACETAMINOPHEN 76 38 S2 84 91
LANTUS 75 47 85 59
IBUPROFEN 75 25 85 55
SULFAMETHOXAZOLE-TRIMETHOPRIM 74 55 87 110
MUPIROCIN 74 50 87 137
GLIPIZIDE 73 50 89 41
ACETAMINOPHEN-CODEINE 72 49 S3 90 149
FLUCONAZOLE 71 31 91 226
DOXAZOSIN MESYLATE 71 59 91 57
DILTIAZEM 24HR CD 68 56 93 155
HUMULIN 70-30 67 33 94 192
HYDRALAZINE HCL 66 47 95 81
METOCLOPRAMIDE HCL 66 36 95 135
AMIODARONE HCL 66 58 95 211
VIAGRA 64 47 98 69
VERAPAMIL ER 64 61 98 99
BENAZEPRIL HCL 64 54 98 71
METHOTREXATE 64 56 98 224
SPIRONOLACTONE 63 53 102 77
MIRTAZAPINE 62 62 103 63
DIOVAN HCT 60 51 104 80
HYDROXYZINE HCL 60 33 R 104 244
CLOTRIMAZOLE-BETAMETHASONE 60 52 104 84
KLOR-CON 8 58 52 107 264
ACYCLOVIR 58 33 107 259
KLOR-CON M10 57 47 109 227
CRESTOR 56 44 110 19
VESICARE 56 56 110 209
BUPROPION HCL SR 56 14 110 249
CLOTRIMAZOLE 53 31 113 375
OXYCODONE HCL-ACETAMINOPHEN 52 21 S2 114 104
DOXEPIN HCL 51 45 115 282
METHADONE HCL 51 0 S2 115 174
VOLTAREN 50 44 117 102
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.